Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with type 2 diabetes mellitus

Diabetic Medicine

Volumn 18, Issue 2, 2001, Pages 109-115

  Mehrotra, S ^a   Ling, K L E ^a   Bekele, Y ^a   Gerbino, E ^a   Earle, K A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ethnic; Microalbuminuria; Nephropathy; Oxidative stress; Von Willebrand factor

Indexed keywords

ALBUMIN; FERROUS ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREDICTION; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CARIBBEAN REGION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPID PEROXIDES; LONDON; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; REGRESSION ANALYSIS; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 0035076182     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00416.x     Document Type: Article

References (32)

1. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes
2. Population need for tenal replacement therapy in Thames regions: Ethnic dimension
3. Role of oxidative stress in development of complications in diabetes
4. Diabetes mellitus, hypertension and cardiovascular disease: Which tole for oxidative stress?
5. The link between hyperglycemia and diabetic nephropathy
6. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions
7. Role of oxidative stress in the development of diabetic nephropathy
8. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals
9. Aminoguanidine a novel inhibitor of nitric oxide formation prevents vascular dysfunction
10. Antioxidant enzyme status and lipid petoxidation in various tissues of diabetic and starved rats
11. Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients
12. Low density lipoprotein is the major cartier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hyroperoxide concentrations
13. Elevated levels of authentic plasma hydroperoxides in NIDDM
14. Increased diene conjugates in diabetic subjects with mictoangio-pathy
15. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications
16. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM
17. End-stage renal failure in type 2 diabetes: A medical catastrophe of woldwide dimensions
18. Effects of blood pressure control on progressive renal disease in Blacks and Whites. Modification of Diet in Renal Disease Study Group
19. Free radical scavenging activity of sulphony-lureas: A clinical assessment of the effect of glicalzide
20. Ciprofibrate therapy improves endothelial function and reduces post-prandial lipemia and oxidative stress in type 2 diabetes
21. Serum markers of oxidative stress and severity of diabetic retinopathy
22. Oxidative stress occurs in the absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats
23. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state
24. Nitric oxide and the kidney
25. Racial differences in the prevalence of microalbuminuria in hypertension
26. Vasodilatation in black Americans: Attenuated nitric oxide mediated responses
27. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: Improved reliability with parallel determnation of the vWf propeptide (vWf: AgII)
28. Endothelial dysfunction precedes development of microalbuminuria in IDDM
29. Von Willebrand factor, C-reactive protein, and 5 year mortality in diabetic and non-diabetic subjects
30. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy
31. LDL subclass phenotypes and triglyceride metabolism in NIDDM